<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">An additional issue to be considered in severely sick patients is cytokine storm associated with disease severity of SARS-CoV-2 [
 <xref rid="bib17" ref-type="bibr">17</xref>].The significant decrease in the production of pro-inflammatory markers and cytokines with HCQ has made this agent a successful disease modifying anti-inflammatory agent in the treatment of various autoimmune diseases including rheumatoid arthritis, systemic lupus erythematosus and Sjogrenâ€™s syndrome. Long-term clinical safety profile of HCQ is better than that of chloroquine, that allows higher daily dose of HCQ with less drug-drug interactions.
</p>
